Literature DB >> 7913951

Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies.

W Richter1, T Mertens, B Schoel, P Muir, A Ritzkowsky, W A Scherbaum, B O Boehm.   

Abstract

Molecular mimicry between viral antigens and host proteins was often suggested to be involved in induction of autoimmune diseases. In type 1 diabetes where pancreatic beta cells are destroyed by autoimmune phenomena, a linear sequence homology between a major autoantigen, glutamate decarboxylase (GAD), and the 2C protein of coxsackie B4 was identified. In addition, a sequence homology between GAD and the mycobacterial heat shock protein 60 was described and the suggestions were made that molecular mimicry between GAD, coxsackievirus B4-2C protein, and/or heat shock protein 60 (hsp60) may be actively involved in an autoimmune reaction towards the pancreatic beta-cells. Our group was the first to isolate human monoclonal autoantibodies to GAD (MICA 1-6) from a patient with newly diagnosed type 1 diabetes. The MICA allowed a detailed characterization of the diabetes associated self-epitopes in GAD and represent a set of GAD autoantibodies present in sera from patients with type 1 diabetes. Using deletion mutants of GAD we demonstrated that the regions of GAD covering the homology sequences to coxsackievirus B4 and to the hsp60 were absolutely required for binding of the MICA to GAD. We now designed an antibody-based analysis to ask whether molecular mimicry between GAD and coxsackie B4-2C or hsp60 is relevant in type 1 diabetes. Since part of the MICA recognize conformational epitopes, they allow to test for conformational molecular mimicry in viruses that have been incriminated in the development of type 1 diabetes. Our data reveal no crossreactivity between the diabetes associated GAD epitopes defined by the MICA and hsp60, rubellavirus, cytomegalovirus, and coxsackie B1-B6 virus antigens. Neither coxsackie B4-specific antibodies in sera from normal individuals nor GAD-positive sera from patients with type 1 diabetes indicated a crossreactivity between coxsackie B4-2C and GAD. Although the regions in GAD homologous to coxsackie B4-2C and hsp60 represented parts of GAD indispensible for binding of diabetes associated autoantibodies they did not mediate a crossreactivity of autoantibodies between GAD and these two proteins. No evidence for molecular mimicry between GAD and a whole panel of foreign antigens was detected by autoantibodies in type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913951      PMCID: PMC2191584          DOI: 10.1084/jem.180.2.721

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.

Authors:  J W Yoon; M Austin; T Onodera; A L Notkins
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

2.  The HLA system in congenital rubella patients with and without diabetes.

Authors:  P Rubinstein; M E Walker; B Fedun; M E Witt; L Z Cooper; F Ginsberg-Fellner
Journal:  Diabetes       Date:  1982-12       Impact factor: 9.461

Review 3.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

4.  Epidemiology of an outbreak in a maternity unit of infections with an antigenic variant of Echovirus 11.

Authors:  T Mertens; H Hager; H J Eggers
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

5.  Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.

Authors:  M L King; A Shaikh; D Bidwell; A Voller; J E Banatvala
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

6.  Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  J Seissler; J Amann; L Mauch; H Haubruck; S Wolfahrt; S Bieg; W Richter; R Holl; E Heinze; W Northemann
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Cross antigenicity among enteroviruses as revealed by immunoblot technique.

Authors:  T Mertens; U Pika; H J Eggers
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

8.  Investigation of the coxsackievirus B3 nonstructural proteins 2B, 2C, and 3AB: generation of specific polyclonal antisera and detection of replicating virus in infected tissue.

Authors:  C Hohenadl; K Klingel; P Rieger; P H Hofschneider; R Kandolf
Journal:  J Virol Methods       Date:  1994-05       Impact factor: 2.014

9.  Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group.

Authors:  A Toniolo; T Onodera; G Jordan; J W Yoon; A L Notkins
Journal:  Diabetes       Date:  1982-06       Impact factor: 9.461

10.  Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole.

Authors:  H J EGGERS; I TAMM
Journal:  J Exp Med       Date:  1961-04-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Bacterial peptides are intensively present throughout the human proteome.

Authors:  Brett Trost; Anthony Kusalik; Guglielmo Lucchese; Darja Kanduc
Journal:  Self Nonself       Date:  2010-01

Review 3.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

Review 4.  Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma.

Authors:  K T Coppieters; A Wiberg; S M Tracy; M G von Herrath
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 5.  Pharmacological approaches to the prevention of autoimmune diabetes.

Authors:  W E Winter; D V House; D Schatz
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 6.  Viral infections in type 1 diabetes mellitus--why the β cells?

Authors:  Anne Op de Beeck; Decio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2016-03-29       Impact factor: 43.330

Review 7.  Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection.

Authors:  Jana Precechtelova; Maria Borsanyiova; Sona Sarmirova; Shubhada Bopegamage
Journal:  J Pathog       Date:  2014-12-10

Review 8.  Molecular mimicry: can epitope mimicry induce autoimmune disease?

Authors:  J M Davies
Journal:  Immunol Cell Biol       Date:  1997-04       Impact factor: 5.126

9.  Viral trigger for type 1 diabetes: pros and cons.

Authors:  Christophe M Filippi; Matthias G von Herrath
Journal:  Diabetes       Date:  2008-11       Impact factor: 9.461

Review 10.  Mechanisms of Beta Cell Dysfunction Associated With Viral Infection.

Authors:  Antje Petzold; Michele Solimena; Klaus-Peter Knoch
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.